People warned of serious eye condition linked to weight loss drugs

US' FDA on Monday warned patients and healthcare providers of potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. FDA said non-arteritic anterior ischemic optic neuropathy (NAION) is a rare condition that can result in acute, painless, decreased vision in one eye, including permanent vision loss.